Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth W Mahaffey

Showing results (21-30 of 635) with videos related to

Pageof 64
Sort By:
Current Cardiology Reports|June 9, 2004
The evaluation and management of dyslipidemia and impaired glucose metabolism during acute coronary syndromesAbhinav Goyal, John L Petersen, Kenneth W Mahaffey
Current Opinion in Cardiology|June 4, 2010
Oral factor Xa inhibitors for the prevention of stroke in atrial fibrillationJonathan P Piccini, Renato D Lopes, Kenneth W Mahaffey
Cardiology and Therapy|July 15, 2020
A Call for a New Paradigm for Diabetes Care in the Era of Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i)Sun H Kim, Tara I Chang, Kenneth W Mahaffey
Drugs|January 27, 2005
Platelet glycoprotein IIb/IIIa receptor antagonists in non-ST segment elevation acute coronary syndromes: a review and guide to patient selectionBrett D Atwater, Matthew T Roe, Kenneth W Mahaffey
Expert Opinion on Drug Safety|January 25, 2018
Anticoagulant and antiplatelet therapy choices for patients with atrial fibrillation one year after coronary stenting or acute coronary syndromeChristoph B Olivier, Mintu P Turakhia, Kenneth W Mahaffey
Current Cardiology Reports|April 10, 2017
Adjuvant Antithrombotic Therapy in TAVRRyan G O'Malley, Kenneth W Mahaffey, William F Fearon
JAMA Cardiology|November 11, 2023
Innovation in Event Adjudication-Human vs MachineKenneth W Mahaffey, C Michael Gibson, Renato D Lopes
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|February 22, 2019
Canagliflozin review - safety and efficacy profile in patients with T2DMHaroon Jakher, Tara I Chang, Marilyn Tan, et al.
Future Cardiology|August 5, 2020
Canagliflozin and cardiovascular outcomes in Type 2 diabetesAshish Sarraju, Gabriela Spencer-Bonilla, Fatima Rodriguez, et al.
Critical Pathways in Cardiology|November 17, 2015
Lost to Follow-up and Withdrawal of Consent in Contemporary Global Cardiovascular Randomized Clinical TrialsFatima Rodriguez, Robert W Harrison, Daniel Wojdyla, et al.
Pageof 64

Showing results (21-30 of 635) with videos related to

Sort By:
Pageof 64
Current Cardiology Reports|June 9, 2004
The evaluation and management of dyslipidemia and impaired glucose metabolism during acute coronary syndromesAbhinav Goyal, John L Petersen, Kenneth W Mahaffey
Current Opinion in Cardiology|June 4, 2010
Oral factor Xa inhibitors for the prevention of stroke in atrial fibrillationJonathan P Piccini, Renato D Lopes, Kenneth W Mahaffey
Cardiology and Therapy|July 15, 2020
A Call for a New Paradigm for Diabetes Care in the Era of Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i)Sun H Kim, Tara I Chang, Kenneth W Mahaffey
Drugs|January 27, 2005
Platelet glycoprotein IIb/IIIa receptor antagonists in non-ST segment elevation acute coronary syndromes: a review and guide to patient selectionBrett D Atwater, Matthew T Roe, Kenneth W Mahaffey
Expert Opinion on Drug Safety|January 25, 2018
Anticoagulant and antiplatelet therapy choices for patients with atrial fibrillation one year after coronary stenting or acute coronary syndromeChristoph B Olivier, Mintu P Turakhia, Kenneth W Mahaffey
Current Cardiology Reports|April 10, 2017
Adjuvant Antithrombotic Therapy in TAVRRyan G O'Malley, Kenneth W Mahaffey, William F Fearon
JAMA Cardiology|November 11, 2023
Innovation in Event Adjudication-Human vs MachineKenneth W Mahaffey, C Michael Gibson, Renato D Lopes
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|February 22, 2019
Canagliflozin review - safety and efficacy profile in patients with T2DMHaroon Jakher, Tara I Chang, Marilyn Tan, et al.
Future Cardiology|August 5, 2020
Canagliflozin and cardiovascular outcomes in Type 2 diabetesAshish Sarraju, Gabriela Spencer-Bonilla, Fatima Rodriguez, et al.
Critical Pathways in Cardiology|November 17, 2015
Lost to Follow-up and Withdrawal of Consent in Contemporary Global Cardiovascular Randomized Clinical TrialsFatima Rodriguez, Robert W Harrison, Daniel Wojdyla, et al.
Pageof 64